VICTORIA WHITT: Open Payments
NPI 1780182253 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,363 in 125 payments from 15 companies in 2025. Trend: 2023 $2,054 · 2024 $1,746 · 2025 $2,363
Food & beverage: $2,246Education: $117
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 37 | $771 |
| GlaxoSmithKline, LLC. | 27 | $452 |
| GENZYME CORPORATION | 14 | $215 |
| Regeneron Healthcare Solutions, Inc. | 14 | $200 |
| Insmed, Inc. | 10 | $146 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| United Therapeutics Corporation | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Philips North America LLC | 3 | $56 |
Products named: DUPIXENT, FASENRA, BREZTRI, NUCALA, TRELEGY ELLIPTA, Arikayce, AIRSUPRA, TEZSPIRE.
Industry payments across VA — which companies pay providers there.
